Form 8-K - Current report:
SEC Accession No. 0001493152-24-040365
Filing Date
2024-10-08
Accepted
2024-10-07 21:39:02
Documents
37
Period of Report
2024-10-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40665
2 ex99-1.htm EX-99.1 21452
3 form8-k_001.jpg GRAPHIC 3050
4 ex99-1_001.jpg GRAPHIC 761976
5 ex99-1_002.jpg GRAPHIC 1167582
6 ex99-1_003.jpg GRAPHIC 1045988
7 ex99-1_004.jpg GRAPHIC 1009351
8 ex99-1_005.jpg GRAPHIC 610738
9 ex99-1_006.jpg GRAPHIC 682196
10 ex99-1_007.jpg GRAPHIC 605111
11 ex99-1_008.jpg GRAPHIC 811925
12 ex99-1_009.jpg GRAPHIC 571977
13 ex99-1_010.jpg GRAPHIC 599186
14 ex99-1_011.jpg GRAPHIC 963014
15 ex99-1_012.jpg GRAPHIC 1026022
16 ex99-1_013.jpg GRAPHIC 1039738
17 ex99-1_014.jpg GRAPHIC 974737
18 ex99-1_015.jpg GRAPHIC 825233
19 ex99-1_016.jpg GRAPHIC 1011899
20 ex99-1_017.jpg GRAPHIC 775168
21 ex99-1_018.jpg GRAPHIC 609419
22 ex99-1_019.jpg GRAPHIC 773086
23 ex99-1_020.jpg GRAPHIC 1103680
24 ex99-1_021.jpg GRAPHIC 847807
25 ex99-1_022.jpg GRAPHIC 536287
  Complete submission text file 0001493152-24-040365.txt   25477177

Data Files

Seq Description Document Type Size
26 XBRL SCHEMA FILE lpcn-20241007.xsd EX-101.SCH 3015
27 XBRL LABEL FILE lpcn-20241007_lab.xml EX-101.LAB 34240
28 XBRL PRESENTATION FILE lpcn-20241007_pre.xml EX-101.PRE 24165
39 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3685
Mailing Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108
Business Address 675 ARAPEEN DRIVE, SUITE 202 SALT LAKE CITY X1 84108 801 994 7383
Lipocine Inc. (Filer) CIK: 0001535955 (see all company filings)

EIN.: 990370688 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36357 | Film No.: 241359030
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)